0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GalNAc-Oligonucleotide Conjugates Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-19S18595
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global GalNAc Oligonucleotide Conjugates Market Research Report 2024
BUY CHAPTERS

Global GalNAc-Oligonucleotide Conjugates Market Research Report 2024

Code: QYRE-Auto-19S18595
Report
November 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

GalNAc-Oligonucleotide Conjugates Market

GalNAc-oligonucleotide conjugates refer to complexes formed by chemically linking N-acetylgalactosamine (GalNAc) molecules with oligonucleotides, such as small interfering RNA (siRNA). These conjugates leverage the properties of GalNAc to specifically target liver cells, thereby enhancing the delivery efficiency and therapeutic effect of the oligonucleotides. GalNAc-oligonucleotide conjugates demonstrate broad application potential in gene therapy, cancer treatment, and research and treatment of other related diseases, particularly in improving drug stability, enhancing cellular uptake, and reducing immunogenicity. This provides an innovative drug delivery strategy for modern medicine.
The global GalNAc-Oligonucleotide Conjugates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for GalNAc-Oligonucleotide Conjugates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GalNAc-Oligonucleotide Conjugates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of GalNAc-Oligonucleotide Conjugates include WuXi XDC, BOCSCI Inc., Creative Biogene, Creative Biolabs, Bachem, Biosynthesis, LGC Biosearch Technologies, Sinopep, Organix, CD Formulation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GalNAc-Oligonucleotide Conjugates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GalNAc-Oligonucleotide Conjugates.
The GalNAc-Oligonucleotide Conjugates market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GalNAc-Oligonucleotide Conjugates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GalNAc-Oligonucleotide Conjugates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of GalNAc-Oligonucleotide Conjugates Market Report

Report Metric Details
Report Name GalNAc-Oligonucleotide Conjugates Market
by Type
  • GalNAc-siRNA Conjugates
  • GalNAc-ASO Conjugates
by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company WuXi XDC, BOCSCI Inc., Creative Biogene, Creative Biolabs, Bachem, Biosynthesis, LGC Biosearch Technologies, Sinopep, Organix, CD Formulation, Maravai LifeSciences (Glen Research), Hitgen, Alnylam Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GalNAc-Oligonucleotide Conjugates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GalNAc-Oligonucleotide Conjugates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the GalNAc-Oligonucleotide Conjugates Market report?

Ans: The main players in the GalNAc-Oligonucleotide Conjugates Market are WuXi XDC, BOCSCI Inc., Creative Biogene, Creative Biolabs, Bachem, Biosynthesis, LGC Biosearch Technologies, Sinopep, Organix, CD Formulation, Maravai LifeSciences (Glen Research), Hitgen, Alnylam Pharmaceuticals

What are the Application segmentation covered in the GalNAc-Oligonucleotide Conjugates Market report?

Ans: The Applications covered in the GalNAc-Oligonucleotide Conjugates Market report are Liver Disorders, Cancer, Neurodegenerative Conditions, Other

What are the Type segmentation covered in the GalNAc-Oligonucleotide Conjugates Market report?

Ans: The Types covered in the GalNAc-Oligonucleotide Conjugates Market report are GalNAc-siRNA Conjugates, GalNAc-ASO Conjugates

Recommended Reports

Oligonucleotide Markets

Gene Therapy Markets

RNA Therapeutics & Conjugates

1 GalNAc-Oligonucleotide Conjugates Market Overview
1.1 Product Definition
1.2 GalNAc-Oligonucleotide Conjugates by Type
1.2.1 Global GalNAc-Oligonucleotide Conjugates Market Value Comparison by Type (2024-2030)
1.2.2 GalNAc-siRNA Conjugates
1.2.3 GalNAc-ASO Conjugates
1.3 GalNAc-Oligonucleotide Conjugates by Application
1.3.1 Global GalNAc-Oligonucleotide Conjugates Market Value by Application (2024-2030)
1.3.2 Liver Disorders
1.3.3 Cancer
1.3.4 Neurodegenerative Conditions
1.3.5 Other
1.4 Global GalNAc-Oligonucleotide Conjugates Market Size Estimates and Forecasts
1.4.1 Global GalNAc-Oligonucleotide Conjugates Revenue 2019-2030
1.4.2 Global GalNAc-Oligonucleotide Conjugates Sales 2019-2030
1.4.3 Global GalNAc-Oligonucleotide Conjugates Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 GalNAc-Oligonucleotide Conjugates Market Competition by Manufacturers
2.1 Global GalNAc-Oligonucleotide Conjugates Sales Market Share by Manufacturers (2019-2024)
2.2 Global GalNAc-Oligonucleotide Conjugates Revenue Market Share by Manufacturers (2019-2024)
2.3 Global GalNAc-Oligonucleotide Conjugates Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of GalNAc-Oligonucleotide Conjugates, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GalNAc-Oligonucleotide Conjugates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GalNAc-Oligonucleotide Conjugates, Product Type & Application
2.7 Global Key Manufacturers of GalNAc-Oligonucleotide Conjugates, Date of Enter into This Industry
2.8 Global GalNAc-Oligonucleotide Conjugates Market Competitive Situation and Trends
2.8.1 Global GalNAc-Oligonucleotide Conjugates Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GalNAc-Oligonucleotide Conjugates Players Market Share by Revenue
2.8.3 Global GalNAc-Oligonucleotide Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GalNAc-Oligonucleotide Conjugates Market Scenario by Region
3.1 Global GalNAc-Oligonucleotide Conjugates Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global GalNAc-Oligonucleotide Conjugates Sales by Region: 2019-2030
3.2.1 Global GalNAc-Oligonucleotide Conjugates Sales by Region: 2019-2024
3.2.2 Global GalNAc-Oligonucleotide Conjugates Sales by Region: 2025-2030
3.3 Global GalNAc-Oligonucleotide Conjugates Revenue by Region: 2019-2030
3.3.1 Global GalNAc-Oligonucleotide Conjugates Revenue by Region: 2019-2024
3.3.2 Global GalNAc-Oligonucleotide Conjugates Revenue by Region: 2025-2030
3.4 North America GalNAc-Oligonucleotide Conjugates Market Facts & Figures by Country
3.4.1 North America GalNAc-Oligonucleotide Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America GalNAc-Oligonucleotide Conjugates Sales by Country (2019-2030)
3.4.3 North America GalNAc-Oligonucleotide Conjugates Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe GalNAc-Oligonucleotide Conjugates Market Facts & Figures by Country
3.5.1 Europe GalNAc-Oligonucleotide Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe GalNAc-Oligonucleotide Conjugates Sales by Country (2019-2030)
3.5.3 Europe GalNAc-Oligonucleotide Conjugates Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GalNAc-Oligonucleotide Conjugates Market Facts & Figures by Region
3.6.1 Asia Pacific GalNAc-Oligonucleotide Conjugates Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific GalNAc-Oligonucleotide Conjugates Sales by Region (2019-2030)
3.6.3 Asia Pacific GalNAc-Oligonucleotide Conjugates Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GalNAc-Oligonucleotide Conjugates Market Facts & Figures by Country
3.7.1 Latin America GalNAc-Oligonucleotide Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America GalNAc-Oligonucleotide Conjugates Sales by Country (2019-2030)
3.7.3 Latin America GalNAc-Oligonucleotide Conjugates Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GalNAc-Oligonucleotide Conjugates Market Facts & Figures by Country
3.8.1 Middle East and Africa GalNAc-Oligonucleotide Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa GalNAc-Oligonucleotide Conjugates Sales by Country (2019-2030)
3.8.3 Middle East and Africa GalNAc-Oligonucleotide Conjugates Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GalNAc-Oligonucleotide Conjugates Sales by Type (2019-2030)
4.1.1 Global GalNAc-Oligonucleotide Conjugates Sales by Type (2019-2024)
4.1.2 Global GalNAc-Oligonucleotide Conjugates Sales by Type (2025-2030)
4.1.3 Global GalNAc-Oligonucleotide Conjugates Sales Market Share by Type (2019-2030)
4.2 Global GalNAc-Oligonucleotide Conjugates Revenue by Type (2019-2030)
4.2.1 Global GalNAc-Oligonucleotide Conjugates Revenue by Type (2019-2024)
4.2.2 Global GalNAc-Oligonucleotide Conjugates Revenue by Type (2025-2030)
4.2.3 Global GalNAc-Oligonucleotide Conjugates Revenue Market Share by Type (2019-2030)
4.3 Global GalNAc-Oligonucleotide Conjugates Price by Type (2019-2030)
5 Segment by Application
5.1 Global GalNAc-Oligonucleotide Conjugates Sales by Application (2019-2030)
5.1.1 Global GalNAc-Oligonucleotide Conjugates Sales by Application (2019-2024)
5.1.2 Global GalNAc-Oligonucleotide Conjugates Sales by Application (2025-2030)
5.1.3 Global GalNAc-Oligonucleotide Conjugates Sales Market Share by Application (2019-2030)
5.2 Global GalNAc-Oligonucleotide Conjugates Revenue by Application (2019-2030)
5.2.1 Global GalNAc-Oligonucleotide Conjugates Revenue by Application (2019-2024)
5.2.2 Global GalNAc-Oligonucleotide Conjugates Revenue by Application (2025-2030)
5.2.3 Global GalNAc-Oligonucleotide Conjugates Revenue Market Share by Application (2019-2030)
5.3 Global GalNAc-Oligonucleotide Conjugates Price by Application (2019-2030)
6 Key Companies Profiled
6.1 WuXi XDC
6.1.1 WuXi XDC Company Information
6.1.2 WuXi XDC Description and Business Overview
6.1.3 WuXi XDC GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.1.4 WuXi XDC GalNAc-Oligonucleotide Conjugates Product Portfolio
6.1.5 WuXi XDC Recent Developments/Updates
6.2 BOCSCI Inc.
6.2.1 BOCSCI Inc. Company Information
6.2.2 BOCSCI Inc. Description and Business Overview
6.2.3 BOCSCI Inc. GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BOCSCI Inc. GalNAc-Oligonucleotide Conjugates Product Portfolio
6.2.5 BOCSCI Inc. Recent Developments/Updates
6.3 Creative Biogene
6.3.1 Creative Biogene Company Information
6.3.2 Creative Biogene Description and Business Overview
6.3.3 Creative Biogene GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Creative Biogene GalNAc-Oligonucleotide Conjugates Product Portfolio
6.3.5 Creative Biogene Recent Developments/Updates
6.4 Creative Biolabs
6.4.1 Creative Biolabs Company Information
6.4.2 Creative Biolabs Description and Business Overview
6.4.3 Creative Biolabs GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Creative Biolabs GalNAc-Oligonucleotide Conjugates Product Portfolio
6.4.5 Creative Biolabs Recent Developments/Updates
6.5 Bachem
6.5.1 Bachem Company Information
6.5.2 Bachem Description and Business Overview
6.5.3 Bachem GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bachem GalNAc-Oligonucleotide Conjugates Product Portfolio
6.5.5 Bachem Recent Developments/Updates
6.6 Biosynthesis
6.6.1 Biosynthesis Company Information
6.6.2 Biosynthesis Description and Business Overview
6.6.3 Biosynthesis GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biosynthesis GalNAc-Oligonucleotide Conjugates Product Portfolio
6.6.5 Biosynthesis Recent Developments/Updates
6.7 LGC Biosearch Technologies
6.7.1 LGC Biosearch Technologies Company Information
6.7.2 LGC Biosearch Technologies Description and Business Overview
6.7.3 LGC Biosearch Technologies GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.7.4 LGC Biosearch Technologies GalNAc-Oligonucleotide Conjugates Product Portfolio
6.7.5 LGC Biosearch Technologies Recent Developments/Updates
6.8 Sinopep
6.8.1 Sinopep Company Information
6.8.2 Sinopep Description and Business Overview
6.8.3 Sinopep GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sinopep GalNAc-Oligonucleotide Conjugates Product Portfolio
6.8.5 Sinopep Recent Developments/Updates
6.9 Organix
6.9.1 Organix Company Information
6.9.2 Organix Description and Business Overview
6.9.3 Organix GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Organix GalNAc-Oligonucleotide Conjugates Product Portfolio
6.9.5 Organix Recent Developments/Updates
6.10 CD Formulation
6.10.1 CD Formulation Company Information
6.10.2 CD Formulation Description and Business Overview
6.10.3 CD Formulation GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CD Formulation GalNAc-Oligonucleotide Conjugates Product Portfolio
6.10.5 CD Formulation Recent Developments/Updates
6.11 Maravai LifeSciences (Glen Research)
6.11.1 Maravai LifeSciences (Glen Research) Company Information
6.11.2 Maravai LifeSciences (Glen Research) Description and Business Overview
6.11.3 Maravai LifeSciences (Glen Research) GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Maravai LifeSciences (Glen Research) GalNAc-Oligonucleotide Conjugates Product Portfolio
6.11.5 Maravai LifeSciences (Glen Research) Recent Developments/Updates
6.12 Hitgen
6.12.1 Hitgen Company Information
6.12.2 Hitgen Description and Business Overview
6.12.3 Hitgen GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hitgen GalNAc-Oligonucleotide Conjugates Product Portfolio
6.12.5 Hitgen Recent Developments/Updates
6.13 Alnylam Pharmaceuticals
6.13.1 Alnylam Pharmaceuticals Company Information
6.13.2 Alnylam Pharmaceuticals Description and Business Overview
6.13.3 Alnylam Pharmaceuticals GalNAc-Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Alnylam Pharmaceuticals GalNAc-Oligonucleotide Conjugates Product Portfolio
6.13.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GalNAc-Oligonucleotide Conjugates Industry Chain Analysis
7.2 GalNAc-Oligonucleotide Conjugates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GalNAc-Oligonucleotide Conjugates Production Mode & Process
7.4 GalNAc-Oligonucleotide Conjugates Sales and Marketing
7.4.1 GalNAc-Oligonucleotide Conjugates Sales Channels
7.4.2 GalNAc-Oligonucleotide Conjugates Distributors
7.5 GalNAc-Oligonucleotide Conjugates Customers
8 GalNAc-Oligonucleotide Conjugates Market Dynamics
8.1 GalNAc-Oligonucleotide Conjugates Industry Trends
8.2 GalNAc-Oligonucleotide Conjugates Market Drivers
8.3 GalNAc-Oligonucleotide Conjugates Market Challenges
8.4 GalNAc-Oligonucleotide Conjugates Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global GalNAc-Oligonucleotide Conjugates Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global GalNAc-Oligonucleotide Conjugates Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global GalNAc-Oligonucleotide Conjugates Market Competitive Situation by Manufacturers in 2023
 Table 4. Global GalNAc-Oligonucleotide Conjugates Sales (Kg) of Key Manufacturers (2019-2024)
 Table 5. Global GalNAc-Oligonucleotide Conjugates Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global GalNAc-Oligonucleotide Conjugates Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global GalNAc-Oligonucleotide Conjugates Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market GalNAc-Oligonucleotide Conjugates Average Price (US $/g) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of GalNAc-Oligonucleotide Conjugates, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GalNAc-Oligonucleotide Conjugates, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GalNAc-Oligonucleotide Conjugates, Product Type & Application
 Table 12. Global Key Manufacturers of GalNAc-Oligonucleotide Conjugates, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GalNAc-Oligonucleotide Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GalNAc-Oligonucleotide Conjugates as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GalNAc-Oligonucleotide Conjugates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global GalNAc-Oligonucleotide Conjugates Sales by Region (2019-2024) & (Kg)
 Table 18. Global GalNAc-Oligonucleotide Conjugates Sales Market Share by Region (2019-2024)
 Table 19. Global GalNAc-Oligonucleotide Conjugates Sales by Region (2025-2030) & (Kg)
 Table 20. Global GalNAc-Oligonucleotide Conjugates Sales Market Share by Region (2025-2030)
 Table 21. Global GalNAc-Oligonucleotide Conjugates Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global GalNAc-Oligonucleotide Conjugates Revenue Market Share by Region (2019-2024)
 Table 23. Global GalNAc-Oligonucleotide Conjugates Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global GalNAc-Oligonucleotide Conjugates Revenue Market Share by Region (2025-2030)
 Table 25. North America GalNAc-Oligonucleotide Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America GalNAc-Oligonucleotide Conjugates Sales by Country (2019-2024) & (Kg)
 Table 27. North America GalNAc-Oligonucleotide Conjugates Sales by Country (2025-2030) & (Kg)
 Table 28. North America GalNAc-Oligonucleotide Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America GalNAc-Oligonucleotide Conjugates Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe GalNAc-Oligonucleotide Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe GalNAc-Oligonucleotide Conjugates Sales by Country (2019-2024) & (Kg)
 Table 32. Europe GalNAc-Oligonucleotide Conjugates Sales by Country (2025-2030) & (Kg)
 Table 33. Europe GalNAc-Oligonucleotide Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe GalNAc-Oligonucleotide Conjugates Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific GalNAc-Oligonucleotide Conjugates Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific GalNAc-Oligonucleotide Conjugates Sales by Region (2019-2024) & (Kg)
 Table 37. Asia Pacific GalNAc-Oligonucleotide Conjugates Sales by Region (2025-2030) & (Kg)
 Table 38. Asia Pacific GalNAc-Oligonucleotide Conjugates Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific GalNAc-Oligonucleotide Conjugates Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America GalNAc-Oligonucleotide Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America GalNAc-Oligonucleotide Conjugates Sales by Country (2019-2024) & (Kg)
 Table 42. Latin America GalNAc-Oligonucleotide Conjugates Sales by Country (2025-2030) & (Kg)
 Table 43. Latin America GalNAc-Oligonucleotide Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America GalNAc-Oligonucleotide Conjugates Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa GalNAc-Oligonucleotide Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa GalNAc-Oligonucleotide Conjugates Sales by Country (2019-2024) & (Kg)
 Table 47. Middle East and Africa GalNAc-Oligonucleotide Conjugates Sales by Country (2025-2030) & (Kg)
 Table 48. Middle East and Africa GalNAc-Oligonucleotide Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa GalNAc-Oligonucleotide Conjugates Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global GalNAc-Oligonucleotide Conjugates Sales (Kg) by Type (2019-2024)
 Table 51. Global GalNAc-Oligonucleotide Conjugates Sales (Kg) by Type (2025-2030)
 Table 52. Global GalNAc-Oligonucleotide Conjugates Sales Market Share by Type (2019-2024)
 Table 53. Global GalNAc-Oligonucleotide Conjugates Sales Market Share by Type (2025-2030)
 Table 54. Global GalNAc-Oligonucleotide Conjugates Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global GalNAc-Oligonucleotide Conjugates Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global GalNAc-Oligonucleotide Conjugates Revenue Market Share by Type (2019-2024)
 Table 57. Global GalNAc-Oligonucleotide Conjugates Revenue Market Share by Type (2025-2030)
 Table 58. Global GalNAc-Oligonucleotide Conjugates Price (US $/g) by Type (2019-2024)
 Table 59. Global GalNAc-Oligonucleotide Conjugates Price (US $/g) by Type (2025-2030)
 Table 60. Global GalNAc-Oligonucleotide Conjugates Sales (Kg) by Application (2019-2024)
 Table 61. Global GalNAc-Oligonucleotide Conjugates Sales (Kg) by Application (2025-2030)
 Table 62. Global GalNAc-Oligonucleotide Conjugates Sales Market Share by Application (2019-2024)
 Table 63. Global GalNAc-Oligonucleotide Conjugates Sales Market Share by Application (2025-2030)
 Table 64. Global GalNAc-Oligonucleotide Conjugates Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global GalNAc-Oligonucleotide Conjugates Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global GalNAc-Oligonucleotide Conjugates Revenue Market Share by Application (2019-2024)
 Table 67. Global GalNAc-Oligonucleotide Conjugates Revenue Market Share by Application (2025-2030)
 Table 68. Global GalNAc-Oligonucleotide Conjugates Price (US $/g) by Application (2019-2024)
 Table 69. Global GalNAc-Oligonucleotide Conjugates Price (US $/g) by Application (2025-2030)
 Table 70. WuXi XDC Company Information
 Table 71. WuXi XDC Description and Business Overview
 Table 72. WuXi XDC GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 73. WuXi XDC GalNAc-Oligonucleotide Conjugates Product
 Table 74. WuXi XDC Recent Developments/Updates
 Table 75. BOCSCI Inc. Company Information
 Table 76. BOCSCI Inc. Description and Business Overview
 Table 77. BOCSCI Inc. GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 78. BOCSCI Inc. GalNAc-Oligonucleotide Conjugates Product
 Table 79. BOCSCI Inc. Recent Developments/Updates
 Table 80. Creative Biogene Company Information
 Table 81. Creative Biogene Description and Business Overview
 Table 82. Creative Biogene GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 83. Creative Biogene GalNAc-Oligonucleotide Conjugates Product
 Table 84. Creative Biogene Recent Developments/Updates
 Table 85. Creative Biolabs Company Information
 Table 86. Creative Biolabs Description and Business Overview
 Table 87. Creative Biolabs GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 88. Creative Biolabs GalNAc-Oligonucleotide Conjugates Product
 Table 89. Creative Biolabs Recent Developments/Updates
 Table 90. Bachem Company Information
 Table 91. Bachem Description and Business Overview
 Table 92. Bachem GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 93. Bachem GalNAc-Oligonucleotide Conjugates Product
 Table 94. Bachem Recent Developments/Updates
 Table 95. Biosynthesis Company Information
 Table 96. Biosynthesis Description and Business Overview
 Table 97. Biosynthesis GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 98. Biosynthesis GalNAc-Oligonucleotide Conjugates Product
 Table 99. Biosynthesis Recent Developments/Updates
 Table 100. LGC Biosearch Technologies Company Information
 Table 101. LGC Biosearch Technologies Description and Business Overview
 Table 102. LGC Biosearch Technologies GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 103. LGC Biosearch Technologies GalNAc-Oligonucleotide Conjugates Product
 Table 104. LGC Biosearch Technologies Recent Developments/Updates
 Table 105. Sinopep Company Information
 Table 106. Sinopep Description and Business Overview
 Table 107. Sinopep GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 108. Sinopep GalNAc-Oligonucleotide Conjugates Product
 Table 109. Sinopep Recent Developments/Updates
 Table 110. Organix Company Information
 Table 111. Organix Description and Business Overview
 Table 112. Organix GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 113. Organix GalNAc-Oligonucleotide Conjugates Product
 Table 114. Organix Recent Developments/Updates
 Table 115. CD Formulation Company Information
 Table 116. CD Formulation Description and Business Overview
 Table 117. CD Formulation GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 118. CD Formulation GalNAc-Oligonucleotide Conjugates Product
 Table 119. CD Formulation Recent Developments/Updates
 Table 120. Maravai LifeSciences (Glen Research) Company Information
 Table 121. Maravai LifeSciences (Glen Research) Description and Business Overview
 Table 122. Maravai LifeSciences (Glen Research) GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 123. Maravai LifeSciences (Glen Research) GalNAc-Oligonucleotide Conjugates Product
 Table 124. Maravai LifeSciences (Glen Research) Recent Developments/Updates
 Table 125. Hitgen Company Information
 Table 126. Hitgen Description and Business Overview
 Table 127. Hitgen GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 128. Hitgen GalNAc-Oligonucleotide Conjugates Product
 Table 129. Hitgen Recent Developments/Updates
 Table 130. Alnylam Pharmaceuticals Company Information
 Table 131. Alnylam Pharmaceuticals Description and Business Overview
 Table 132. Alnylam Pharmaceuticals GalNAc-Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US $/g) and Gross Margin (2019-2024)
 Table 133. Alnylam Pharmaceuticals GalNAc-Oligonucleotide Conjugates Product
 Table 134. Alnylam Pharmaceuticals Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. GalNAc-Oligonucleotide Conjugates Distributors List
 Table 138. GalNAc-Oligonucleotide Conjugates Customers List
 Table 139. GalNAc-Oligonucleotide Conjugates Market Trends
 Table 140. GalNAc-Oligonucleotide Conjugates Market Drivers
 Table 141. GalNAc-Oligonucleotide Conjugates Market Challenges
 Table 142. GalNAc-Oligonucleotide Conjugates Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GalNAc-Oligonucleotide Conjugates
 Figure 2. Global GalNAc-Oligonucleotide Conjugates Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global GalNAc-Oligonucleotide Conjugates Market Share by Type: 2023 & 2030
 Figure 4. GalNAc-siRNA Conjugates Product Picture
 Figure 5. GalNAc-ASO Conjugates Product Picture
 Figure 6. Global GalNAc-Oligonucleotide Conjugates Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global GalNAc-Oligonucleotide Conjugates Market Share by Application: 2023 & 2030
 Figure 8. Liver Disorders
 Figure 9. Cancer
 Figure 10. Neurodegenerative Conditions
 Figure 11. Other
 Figure 12. Global GalNAc-Oligonucleotide Conjugates Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global GalNAc-Oligonucleotide Conjugates Market Size (2019-2030) & (US$ Million)
 Figure 14. Global GalNAc-Oligonucleotide Conjugates Sales (2019-2030) & (Kg)
 Figure 15. Global GalNAc-Oligonucleotide Conjugates Average Price (US $/g) & (2019-2030)
 Figure 16. GalNAc-Oligonucleotide Conjugates Report Years Considered
 Figure 17. GalNAc-Oligonucleotide Conjugates Sales Share by Manufacturers in 2023
 Figure 18. Global GalNAc-Oligonucleotide Conjugates Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest GalNAc-Oligonucleotide Conjugates Players: Market Share by Revenue in GalNAc-Oligonucleotide Conjugates in 2023
 Figure 20. GalNAc-Oligonucleotide Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global GalNAc-Oligonucleotide Conjugates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America GalNAc-Oligonucleotide Conjugates Sales Market Share by Country (2019-2030)
 Figure 23. North America GalNAc-Oligonucleotide Conjugates Revenue Market Share by Country (2019-2030)
 Figure 24. United States GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe GalNAc-Oligonucleotide Conjugates Sales Market Share by Country (2019-2030)
 Figure 27. Europe GalNAc-Oligonucleotide Conjugates Revenue Market Share by Country (2019-2030)
 Figure 28. Germany GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific GalNAc-Oligonucleotide Conjugates Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific GalNAc-Oligonucleotide Conjugates Revenue Market Share by Region (2019-2030)
 Figure 35. China GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America GalNAc-Oligonucleotide Conjugates Sales Market Share by Country (2019-2030)
 Figure 43. Mexico GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa GalNAc-Oligonucleotide Conjugates Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa GalNAc-Oligonucleotide Conjugates Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE GalNAc-Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of GalNAc-Oligonucleotide Conjugates by Type (2019-2030)
 Figure 53. Global Revenue Market Share of GalNAc-Oligonucleotide Conjugates by Type (2019-2030)
 Figure 54. Global GalNAc-Oligonucleotide Conjugates Price (US $/g) by Type (2019-2030)
 Figure 55. Global Sales Market Share of GalNAc-Oligonucleotide Conjugates by Application (2019-2030)
 Figure 56. Global Revenue Market Share of GalNAc-Oligonucleotide Conjugates by Application (2019-2030)
 Figure 57. Global GalNAc-Oligonucleotide Conjugates Price (US $/g) by Application (2019-2030)
 Figure 58. GalNAc-Oligonucleotide Conjugates Value Chain
 Figure 59. GalNAc-Oligonucleotide Conjugates Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart